InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 06/18/2019 1:50:42 PM

Tuesday, June 18, 2019 1:50:42 PM

Post# of 346
News: $CBAY CymaBay Therapeutics Announces IND to Commence a Clinical Study of Seladelpar to Treat Primary Sclerosing Cholangitis

NEWARK, Calif., June 18, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases, today announced FDA clearance of the company’...

Read the whole news https://marketwirenews.com/news-releases/cymabay-therapeutics-announces-ind-to-commence-a-clinical-study-of-seladelpar-to-treat-primary-sclerosing-cholangitis-8373898.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CBAY News